Recent Quotes

My Watchlist

Top Indices

Johnson & Johnson (NY:JNJ)

203.06 +1.12 (+0.56%)

Streaming Delayed Price Updated: 11:50 AM EST, Dec 8, 2025 Add to My Watchlist

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Tech Titans and Consumer Giants Reshape Markets: Amazon's AI Leap and Kimberly-Clark's Mega-Merger

November 03, 2025

November 3, 2025, marks a pivotal day in the financial markets, witnessing two seismic corporate announcements that promise to redefine their respective industries. Amazon.com Inc. (NASDAQ: AMZN) has...

Via MarketMinute

Buffett Sells Stocks – Here Is What Prudent Investors Should Do Now; OPEC+ Changes Stance ↗

November 03, 2025

Buffett Sells Stocks Please click here for a chart of Warren Buffett’s company Berkshire Hathaway Inc Class B (NYSE:

Via Benzinga

Dow Jones Extends Gains as Palantir Eyes AI-Driven Surge and Kenvue Soars on Kimberly-Clark Takeover

November 03, 2025

New York, NY – November 3, 2025 – The Dow Jones Industrial Average is on track to extend its robust gains as the market closes out a strong trading day, buoyed by a confluence of positive factors...

Via MarketMinute

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On? ↗

November 03, 2025

Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE: KVUE).

Via Benzinga

Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks? ↗

November 03, 2025

Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, there are still some lingering impacts to consider.

Via The Motley Fool

Johnson & Johnson Stock: Is Wall Street Bullish or Bearish?

November 03, 2025

Johnson & Johnson has delivered a standout performance in 2025, outperforming both the broader market and the healthcare sector. Analysts continue to be fairly bullish on the stock’s trajectory.

Via Barchart.com

Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout

October 31, 2025

Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant...

Via MarketMinute

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine

October 31, 2025

Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to...

Via TokenRing AI

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations ↗

October 30, 2025

Via MarketBeat

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗

October 30, 2025

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.

Via Benzinga

Navigating the Aftermath: What Lies Ahead for Markets Post-Decline

October 30, 2025

The financial markets are grappling with the reverberations of a significant day of declines, leaving investors and analysts alike pondering the immediate and long-term trajectory. This recent downturn...

Via MarketMinute

From Record Heights to Pullback: Analyzing the Current Market Correction

October 30, 2025

The global financial markets, which had soared to unprecedented valuations through late 2024 and early 2025, experienced a sharp and unsettling correction in April 2025. This significant downturn,...

Via MarketMinute

S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025

October 29, 2025

On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P...

Via MarketMinute

Navigating the Aftermath: Market Outlook Post-Declines Amidst Trade Truce and Rate Uncertainty

October 30, 2025

The global financial markets, as of October 30, 2025, are grappling with a complex interplay of factors, following a day characterized by stock futures pointing to a lower open and investor caution....

Via MarketMinute

S&P 500: Decoding the Daily Market Pulse on October 29, 2025

October 29, 2025

As the trading day of October 29, 2025, draws to a close, investors and analysts alike are keenly focused on the S&P 500, the bellwether index for the U.S. stock market. Representing 500 of the largest...

Via MarketMinute

Market Mania: Soaring Investor Confidence Propels Global Indices to Uncharted Heights

October 29, 2025

As October 29, 2025, dawns, financial markets are awash with an extraordinary wave of investor confidence, a sentiment so potent it is propelling major global indices to unprecedented record highs....

Via MarketMinute

Navigating the Financial Tides: An Investor's Timeless Guide to Bull and Bear Markets

October 29, 2025

In the dynamic world of financial markets, two iconic figures dominate the landscape: the Bull and the Bear. These powerful symbols represent the contrasting forces that drive asset prices, investor...

Via MarketMinute

Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability

October 29, 2025

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END

Via FinancialNewsMedia

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety ↗

October 28, 2025

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women.

Via Benzinga

Kenvue Stock Drops After Texas Attorney General Sues Company Alleging Deceptive Marketing Of Tylenol ↗

October 28, 2025

The lawsuit comes on the heels of President Trump linking Tylenol to autism.

Via Stocktwits

2 Dividend Stocks to Double Up on Right Now ↗

October 28, 2025

They are about as safe as dividends can get.

Via The Motley Fool

Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers

October 27, 2025

As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the...

Via MarketMinute

Market Alarms Blare: Buffett Indicator and Shiller CAPE Ratio Signal Potential 2026 Stock Market Crash

October 27, 2025

As the calendar turns towards late 2025, prominent valuation metrics, the "Buffett Indicator" and the "Shiller CAPE Ratio," are flashing crimson, sending strong signals of a potentially significant...

Via MarketMinute

Market's Perilous Peak: Is the U.S. Stock Market More Overvalued Than Ever?

October 27, 2025

New York, NY – October 27, 2025 – A chorus of concern is growing louder across financial markets, with prominent voices like MarketWatch raising alarm bells over what they describe as an unprecedented...

Via MarketMinute

Dow Jones Soars to New Record High Amidst Wave of Optimism, Signaling Robust Market Confidence

October 27, 2025

The Dow Jones Industrial Average (DJIA) recently achieved a significant milestone, surging by over 200 points to close at an unprecedented all-time record high in October 2025. This remarkable ascent...

Via MarketMinute

3 Healthcare Stocks to Buy Hand Over Fist in October ↗

October 27, 2025

One growth stock, one high-yield stock, and one Dividend King -- you should find something you like here as October draws to a close.

Via The Motley Fool

Warren Buffett's Investing Playbook -- Simplified for First-Time Stock Buyers ↗

October 27, 2025

Want to invest like Buffett? You don't need billions of dollars -- just a long-term mindset and the discipline to stay consistent.

Via The Motley Fool

3 Healthcare Stocks Paying the Highest Dividends of 2025 ↗

October 27, 2025

If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.